Advertisement
Advertisement
February 16, 2021
Front Line Medical’s Cobra-OS Device Receives Health Canada Approval
February 16, 2021—Front Line Medical Technologies, Inc. announced that it has received Health Canada approval for its Control of Bleeding, Resuscitation, Arterial Occlusion System (Cobra-OS) device. The Cobra-OS is a resuscitative endovascular balloon occlusion of the aorta (REBOA) device designed for use in emergencies when patients require hemodynamic support to maintain blood flow to the brain and heart.
According to the company, the Cobra-OS is an easy-to-use aortic occlusion device with a low profile for temporary hemorrhage control and resuscitation. The company also noted that it is the first 4-F REBOA device, making it the smallest on the market, and its decreased size is designed for quick and easy deployment, reducing the time of the procedure and potentially improving patient outcomes.
Adam Power, practicing vascular surgeon and cofounder of Front Line Medical Technologies, stated in the announcement, “Even with all the advances in medicine today, trauma patients are primarily still dying from blood loss—this is our chance to change that. While REBOA continues to emerge as a life-saving procedure, we saw the need for a simple, fast, low-profile device to maximize its benefit and ultimately save more lives.”
Advertisement
Advertisement
